{
    "Trade/Device Name(s)": [
        "HE4 EIA Kit"
    ],
    "Submitter Information": "Fujirebio Diagnostics, Inc.",
    "510(k) Number": "K072939",
    "Predicate Device Reference 510(k) Number(s)": [
        "K042731"
    ],
    "Regulatory Class": "Class III",
    "Product Code(s)": [
        "OIU"
    ],
    "Summary Letter Date": "May 29, 2008",
    "Summary Letter Received Date": "May 30, 2008",
    "Submission Date": "May 13, 2008",
    "Regulation Number(s)": [
        "21 CFR 866.6010"
    ],
    "Regulation Name(s)": [
        "Tumor-associated antigen immunological test system"
    ],
    "Analyte Class(es)": [
        "cancer molecular",
        "immunology"
    ],
    "Analyte(s)": [
        "HE4"
    ],
    "Specimen Type(s)": [
        "Serum"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "Microplate spectrophotometer"
    ],
    "Method(s)/Technology(ies)": [
        "Enzyme immunometric assay (EIA)",
        "Direct sandwich immunoassay"
    ],
    "Methodologies": [
        "Immunoassay"
    ],
    "Submission Type(s)": [
        "Assay",
        "Kit"
    ],
    "Document Summary": "FDA 510(k) summary for Fujirebio Diagnostics HE4 EIA Kit, an enzyme immunometric assay for quantitative HE4 determination in human serum to aid monitoring of epithelial ovarian cancer.",
    "Indications for Use Summary": "Used as an aid in monitoring recurrence or progressive disease in patients with epithelial ovarian cancer via quantitative determination of HE4 in human serum; serial testing to be used alongside other clinical monitoring methods.",
    "fda_folder": "Immunology"
}